Cas:873679-92-6 Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl manufacturer & supplier

Chemical Name:Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl

CAS.NO:873679-92-6

Synonyms:1-[(5-Bromo-2-methoxyphenyl)sulfonyl]-4-ethylpiperazine;Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl-;1-((5-bromo-2-methoxyphenyl)sulfonyl)-4-ethylpiperazine

Molecular Formula:C₁₃H₁₉BrN₂O₃S

Molecular Weight:363.271

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:464.8±55.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.570

PSA:58.23000

Exact Mass:362.029968

LogP:3.35

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-[(5-Bromo-2-methoxyphenyl)sulfonyl]-4-ethylpiperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-((5-bromo-2-methoxyphenyl)sulfonyl)-4-ethylpiperazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-((5-bromo-2-methoxyphenyl)sulfonyl)-4-ethylpiperazine Use and application,1-((5-bromo-2-methoxyphenyl)sulfonyl)-4-ethylpiperazine technical grade,usp/ep/jp grade.

Related News: AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl manufacturer Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl supplier After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl vendor Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. Piperazine, 1-[(5-bromo-2-methoxyphenyl)sulfonyl]-4-ethyl factory Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.